A detailed history of Insight Folios Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Insight Folios Inc holds 2,691 shares of ABT stock, worth $308,819. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,691
Previous 2,604 3.34%
Holding current value
$308,819
Previous $270,000 13.33%
% of portfolio
0.11%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$100.07 - $118.13 $8,706 - $10,277
87 Added 3.34%
2,691 $306,000
Q2 2024

Jul 18, 2024

BUY
$100.73 - $112.44 $9,267 - $10,344
92 Added 3.66%
2,604 $270,000
Q1 2024

Apr 19, 2024

SELL
$109.52 - $120.96 $16,647 - $18,385
-152 Reduced 5.71%
2,512 $285,000
Q4 2023

Jan 10, 2024

SELL
$90.19 - $110.4 $2,525 - $3,091
-28 Reduced 1.04%
2,664 $293,000
Q3 2023

Oct 11, 2023

SELL
$95.53 - $114.62 $19,774 - $23,726
-207 Reduced 7.14%
2,692 $260,000
Q2 2023

Jul 21, 2023

SELL
$100.78 - $112.29 $3,829 - $4,267
-38 Reduced 1.29%
2,899 $316,000
Q1 2023

Apr 18, 2023

SELL
$96.86 - $114.01 $1,065 - $1,254
-11 Reduced 0.37%
2,937 $297,000
Q4 2022

Jan 17, 2023

BUY
$95.06 - $111.52 $10,171 - $11,932
107 Added 3.77%
2,948 $0
Q3 2022

Oct 19, 2022

BUY
$96.76 - $112.03 $18,964 - $21,957
196 Added 7.41%
2,841 $275,000
Q2 2022

Jul 12, 2022

SELL
$102.07 - $123.37 $1,122 - $1,357
-11 Reduced 0.41%
2,645 $287,000
Q1 2022

Apr 18, 2022

BUY
$114.02 - $139.04 $27,250 - $33,230
239 Added 9.89%
2,656 $314,000
Q4 2021

Jan 20, 2022

BUY
$115.53 - $141.46 $9,588 - $11,741
83 Added 3.56%
2,417 $340,000
Q3 2021

Oct 15, 2021

BUY
$116.66 - $129.06 $19,598 - $21,682
168 Added 7.76%
2,334 $276,000
Q2 2021

Jul 16, 2021

BUY
$105.79 - $124.53 $229,141 - $269,731
2,166 New
2,166 $251,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Insight Folios Inc Portfolio

Follow Insight Folios Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Folios Inc, based on Form 13F filings with the SEC.

News

Stay updated on Insight Folios Inc with notifications on news.